CA1149811A - Indole and indoline derivatives - Google Patents

Indole and indoline derivatives

Info

Publication number
CA1149811A
CA1149811A CA000380032A CA380032A CA1149811A CA 1149811 A CA1149811 A CA 1149811A CA 000380032 A CA000380032 A CA 000380032A CA 380032 A CA380032 A CA 380032A CA 1149811 A CA1149811 A CA 1149811A
Authority
CA
Canada
Prior art keywords
indole
carbon atoms
general formula
alkyl group
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000380032A
Other languages
English (en)
French (fr)
Inventor
Andrew W. Bridge
Michael J. Ashton
Anthony H. Loveless
Robert F. Chapman
Garry Fenton
David Riddell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Application granted granted Critical
Publication of CA1149811A publication Critical patent/CA1149811A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA000380032A 1980-06-18 1981-06-17 Indole and indoline derivatives Expired CA1149811A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8019948 1980-06-18
GB8019948 1980-06-18

Publications (1)

Publication Number Publication Date
CA1149811A true CA1149811A (en) 1983-07-12

Family

ID=10514138

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000380032A Expired CA1149811A (en) 1980-06-18 1981-06-17 Indole and indoline derivatives

Country Status (22)

Country Link
US (1) US4493843A (enExample)
EP (1) EP0042298B1 (enExample)
JP (1) JPS5728048A (enExample)
KR (1) KR850001470B1 (enExample)
AT (1) ATE9329T1 (enExample)
AU (1) AU539678B2 (enExample)
CA (1) CA1149811A (enExample)
DE (1) DE3165998D1 (enExample)
DK (1) DK264281A (enExample)
ES (4) ES8300091A1 (enExample)
FI (1) FI811889A7 (enExample)
GB (1) GB2078736B (enExample)
GR (1) GR75701B (enExample)
HK (2) HK92684A (enExample)
HU (1) HU183480B (enExample)
IE (1) IE52102B1 (enExample)
IL (1) IL63110A (enExample)
MY (2) MY8500975A (enExample)
NZ (1) NZ197441A (enExample)
PH (1) PH16357A (enExample)
SG (2) SG68984G (enExample)
ZA (1) ZA814057B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
SK2612001A3 (en) * 1998-08-26 2001-11-06 Aventis Pharma Ltd Aza-bicycles which modulate the inhibition of cell adhesion
WO2001044184A1 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Synthesis of indole-containing spla2 inhibitors
AU2003247390A1 (en) 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc. Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
DE602005012380D1 (de) * 2004-03-15 2009-03-05 Lilly Co Eli 4-(5-(aminomethyl)-indol-1-ylmethyl)benzamidderivate und verwandte verbindungen als opioidrezeptorantagonisten zur behandlung von fettleibigkeit
JP6217561B2 (ja) * 2014-08-21 2017-10-25 信越化学工業株式会社 新規オニウム塩化合物及びレジスト組成物並びにパターン形成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076814A (en) * 1954-04-28 1963-02-05 Upjohn Co Novel process for the preparation of tryptophols and to novel compounds produced therein
DE2237361A1 (de) * 1972-07-29 1974-02-14 Boehringer Mannheim Gmbh (5-indolyloxy)-essigsaeure-derivate und verfahren zur herstellung derselben
US3992392A (en) * 1973-04-27 1976-11-16 The Ohio State University Research Foundation Synthesis of indoles from anilines and intermediates therein
US3901899A (en) * 1973-04-27 1975-08-26 Univ Ohio State Res Found Synthesis of indoles from anilines and intermediates therein
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
DE2909779A1 (de) * 1979-03-13 1980-09-18 Thomae Gmbh Dr K Neue indolderivate, deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
EP0042298A1 (en) 1981-12-23
IE52102B1 (en) 1987-06-24
FI811889L (fi) 1981-12-19
GB2078736A (en) 1982-01-13
IL63110A (en) 1986-10-31
ES8303333A1 (es) 1983-02-01
NZ197441A (en) 1984-11-09
ES8303332A1 (es) 1983-02-01
GB2078736B (en) 1984-03-07
ES503097A0 (es) 1982-10-01
ATE9329T1 (de) 1984-09-15
US4493843A (en) 1985-01-15
ES8305327A1 (es) 1983-04-01
KR850001470B1 (ko) 1985-10-10
HK92684A (en) 1984-11-30
HK92485A (en) 1985-11-29
ZA814057B (en) 1982-07-28
AU539678B2 (en) 1984-10-11
KR830006205A (ko) 1983-09-20
ES512705A0 (es) 1983-02-01
DE3165998D1 (de) 1984-10-18
PH16357A (en) 1983-09-05
FI811889A7 (fi) 1981-12-19
JPS5728048A (en) 1982-02-15
SG73085G (en) 1986-05-02
DK264281A (da) 1981-12-19
AU7186481A (en) 1981-12-24
EP0042298B1 (en) 1984-09-12
SG68984G (en) 1985-03-15
ES8300091A1 (es) 1982-10-01
ES512704A0 (es) 1983-02-01
ES512706A0 (es) 1983-04-01
GR75701B (enExample) 1984-08-02
MY8500975A (en) 1985-12-31
MY8600409A (en) 1986-12-31
IE811344L (en) 1981-12-18
HU183480B (en) 1984-05-28

Similar Documents

Publication Publication Date Title
US5554642A (en) Arylalkyl(thio) amides
DE69224697T2 (de) Verbindungen, nützlich als leukotriene Antagonisten
CA1317955C (en) 3-¬4(1-substituted-4-piperazinyl)butyl|-4- thiazolidinones a process for their preparation and their use as medicaments
NO136793B (no) Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater.
NO155884B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
EP0677042B1 (fr) Ligands selectifs des recepteurs 5ht1d-5ht1b derives d'indole-piperazine utiles comme medicaments
SU508199A3 (ru) Способ получени производных морфолина
US3960911A (en) Ferrocene compounds and preparation
US3996366A (en) Thio derivatives of imidazol-1-yl carboxamides
DE3542698A1 (de) Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen
NO134547B (enExample)
BE823841A (fr) Derives de 5-(1-hydroxy-2-amino substitue) alkyl-8-carbostyryle substitue et de 5-(1-hydroxy-2-amino substitue) alkyl-8-(3,4-dihydro) carbostyryle substitue et leur procede de preparation
DE3700407A1 (de) Indolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
NO158379B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroalifatiske forbindelser.
US4258059A (en) Amino-benzamides
US3255249A (en) 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols
US3016403A (en) 1-aryl-3-hydroxypropyl sulfones and processes
US4493843A (en) Indole and indoline carboxylic acid compounds and method of use
US2759972A (en) 2-amino and acylamino-1-(hydrocarbylsulphonylphenyl)-1, 3-propanediols
IE48934B1 (en) N-phenylindoline derivatives,their production and pharmaceutical compositions containing them
DE3300522C2 (enExample)
DE69111541T2 (de) Neue Indol- und Indolin-Verbindungen.
US4927819A (en) Cyclo-octane neuroprotective agents
Cannon et al. Studies of Imidazoles. VII. Substituted 1-Phenethylimidazoles and Related Compounds*, 1
JP2839468B2 (ja) 新規なｏ−アリールメチル−ｎ−（チオ）アシルヒドロキシルアミン、その製造方法及びそれを含有する薬学的組成物

Legal Events

Date Code Title Description
MKEX Expiry